Ultragenyx Pharmaceutical Inc.
RARE | NASDAQ
$16.05
+$1.40 (+9.56%)
Sep 22, 2026, 12:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 434M | 173.73M | 213.58M | 132.94M | 307.58M | 713.53M |
Short-Term Investments | 259M | 436.3M | 363.63M | 614.82M | 432.61M | 488.01M |
Long-Term Investments | 59M | 135M | 199.9M | 148.97M | 293.86M | 165.88M |
Other Long-Term Assets | 35M | 62.68M | 57.69M | 48.34M | 20.56M | 8.81M |
Receivables | 159M | 121.8M | 73.39M | 40.45M | 44.43M | 23.09M |
Inventory | 52M | 45.01M | 33.97M | 26.77M | 16.23M | 13.05M |
Other Current Assets | 47M | 40.29M | 47.62M | 68.93M | 55.75M | n/a |
Total Current Assets | 951M | 817.12M | 732.18M | 883.9M | 856.6M | 1.3B |
Property-Plant & Equipment | 267M | 265.93M | 290.57M | 259.73M | 176.18M | 114.04M |
Goodwill & Intangibles | 220M | 222.72M | 210.68M | 204.51M | 175.19M | 175.52M |
Total Long-Term Assets | 581M | 686.33M | 758.83M | 661.55M | 665.79M | 464.25M |
Total Assets | 1.53B | 1.5B | 1.49B | 1.55B | 1.52B | 1.76B |
Account Payables | 31M | 38.76M | 42.11M | 43.27M | 17.14M | 12.92M |
Deferred Revenue | n/a | n/a | n/a | 1.48M | 7.61M | 59.22M |
Short-Term Debt | 81M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 183M | 87.47M | 142.79M | n/a | n/a | n/a |
Total Current Liabilities | 384M | 344.15M | 280.44M | 261.21M | 181.37M | 189.61M |
Long-Term Debt | 1.17B | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | -4M | 836.91M | 874.53M | 880.26M | 352.79M | 335.67M |
Total Long-Term Liabilities | 1.22B | 897.01M | 935.16M | 931.74M | 418.47M | 415.57M |
Total Liabilities | 1.61B | 1.24B | 1.22B | 1.19B | 599.84M | 605.18M |
Total Debt | 1.28B | 40.34M | 43.17M | 31.59M | 41.97M | 48.23M |
Book Value | -73M | 262.3M | 275.41M | 352.49M | 922.56M | 1.15B |
Book Value Per Share | -0.74 | 2.90 | 3.74 | 5.04 | 13.61 | 18.97 |
Common Stock | n/a | 92K | 82K | 70K | 69K | 67K |
Retained Earnings | -4.53B | -3.96B | -3.39B | -2.78B | -2.07B | -1.62B |
Comprehensive Income | 1M | -643K | 647K | -6.57M | -1.4M | 689K |
Shareholders Equity | -80M | 255.3M | 275.41M | 352.49M | 922.56M | 1.15B |
Total Investments | 318M | 571.3M | 563.53M | 763.79M | 726.47M | 653.89M |
Add to Watchlist
Select watchlists to add or remove RARE